Vicarious Surgical Inc.
NYSE:RBOT
7.5 (USD) • At close June 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 2.107 | 1.854 | 0 | 0 | 0 | 0 |
| Gross Profit
| -2.107 | -1.854 | -1.94 | -0.316 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 40.155 | 47.578 | 43.9 | 22.1 | 9.796 | 7.479 |
| General & Administrative Expenses
| 21.875 | 26.858 | 29.715 | 13.203 | 2.328 | 2.054 |
| Selling & Marketing Expenses
| 4.525 | 6.23 | 6.463 | 2.976 | 0.861 | 0.25 |
| SG&A
| 26.4 | 33.088 | 36.178 | 16.164 | 3.189 | 2.304 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 66.555 | 80.666 | 80.078 | 38.574 | 12.985 | 9.783 |
| Operating Income
| -66.555 | -80.666 | -80.078 | -38.223 | -12.985 | -9.783 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 3.332 | 9.595 | 85.235 | 3.016 | 0.11 | 0.469 |
| Income Before Tax
| -63.223 | -71.071 | 5.157 | -35.207 | -12.875 | -9.314 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -84 | -0.227 | 0.003 | -0.068 |
| Net Income
| -63.223 | -71.071 | 5.157 | -35.207 | -12.875 | -9.314 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -10.72 | -14.7 | 0.04 | -2.19 | -0.11 | -1.7 |
| EPS Diluted
| -10.72 | -14.6 | 0.04 | -2.19 | -0.11 | -1.7 |
| EBITDA
| -61.116 | -69.192 | 7.297 | -34.802 | -0.161 | -9.679 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |